Study Principal Investigator: Felix Böhm, MD, PhD
Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Study Co-investigator: Andreas Rück, MD, PhD
Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Study Chair: Stefan James, MD, Professor
Department of Medical Sciences, Uppsala University, Sweden.
Sponsor: Karolinska University Hospital, Stockholm, Sweden.
Steering committee: One investigator from each site will be represented.
Participating sites: Click on the flags on the Starting page.
National coordinators
Sweden: Andreas Rück, Karolinska
Norway: Eigil Fossum, OUS Ullevål, Oslo
Denmark: Thomas Engstrøm, Rigshospitalet, Copenhagen
Iceland: Thorarinn Gudnasson, Reykjavik
Finland: Mika Laine, Helsinki University Hospital
Latvia: Andrejs Erglis, Riga
Lithuania: Andrej Pileckij, Klaipeda
Australia: Carl Schultz, Perth
UK - Scotland: Colin Berry, (UK Chief Investigator)
UK - England: Anthony Gershlick, (UK Co-Chief Investigator)
Serbia: Goran Stankovic, Belgrade
Germany: Christoph Liebtrau, Bad Nauheim
New Zealand: Madhav Menon, Hamilton
FULL REVASC Study team
Uppsala Clinical Research Center (UCR), Uppsala, Sweden:
Project managers: Ulla Nässander Schikan, fullrevasc@ucr.uu.se
Susanne Johansson, fullrevasc@ucr.uu.se
Monitors: Åsa Michelgård Palmquist, fullrevasc@ucr.uu.se
Caroline Moberg, fullrevasc@ucr.uu.se
Admin: Susanna Thörnqvist, fullrevasc.admin@ucr.uu.se
Data manager: Åsa Eck
Statistician: Ollie Östlund
Clinical Events Adjudication: Kai Eggers
Health economist: Sophie Langenskiöld, Uppsala University
DSMB: Nico Pijls (The Netherlands), Bernard De Bruyne (Belgium), Nils Johnson (USA), William F Fearon (USA).
